CMP vs CSX

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

CMP

COMPUMEDIC FPO [CMP]

52MEDIUM

CSX

CLEANSPACE FPO [CSX]

52MEDIUM

Score Breakdown

CMP CSX
Technical
50
53
Catalyst
51
50
Sentiment
50
50
Fundamental
90
95
Momentum
68
59
Risk Gate
47
47

Key Metrics

CMP Metric CSX
$57.9MMarket Cap$38.2M
69KAvg Volume (20d)16K
N/AShort InterestN/A
$0.45052-Week High$0.880
$0.24052-Week Low$0.370
+1.8%Daily Change+0.0%
$0.290Entry Price$0.465
+0.5%ROE+8.8%
+0.2%Profit Margin+8.5%

Active Signals

CMP Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Trading below both moving averages — the trend is working against this one
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.0x)
●Strong revenue growth (+32%)
●Small-cap ($20-100M)

CSX Signals

●RSI is looking oversold — historically a spot where stocks tend to bounce
●MACD momentum is picking up steam
●Trading below both moving averages — the trend is working against this one
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.8x)
●Moderate revenue growth (+10%)
●Piotroski F-Score strong (8/9, low-confidence approx)

Ask Scout AI to compare CMP and CSX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CMP Full Analysis → CSX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).